SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
McAvoy David R.

(Last) (First) (Middle)
3000 KENT AVE., SUITE A1-100

(Street)
WEST LAFAYETTE IN 47906

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
11/08/2018
3. Issuer Name and Ticker or Trading Symbol
ENDOCYTE INC [ ECYT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
General Counsel
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 24,185(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) (2) 01/05/2028 Common Stock 37,500 2.96 D
Explanation of Responses:
1. Represents 435 shares held directly and 23,750 restricted stock units (RSUs) that will vest 1/4 annually over a period of 4 years beginning 2/5/19 in the form of one share of common stock for each RSU.
2. Shares subject to the option will vest 1/4 annually over a period of 4 years beginning on 2/5/19.
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney
/s/ Beth A. Taylor, Attorney-in-Fact for David R. McAvoy 11/15/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
              Limited Power of Attorney Securities Law Compliance

      The  undersigned,  as  an  officer  or  director  of  Endocyte,  Inc. (the
"Company"),  hereby  constitutes  and  appoints  Michael  A. Sherman and Beth A.
Taylor, and each of them, the undersigned's true and lawful attorney in fact and
agent  to  complete  and  execute  such Forms 144, Forms 3, 4 and 5, Form ID and
other  forms  as  such  attorney  shall in his or her discretion determine to be
required  or advisable pursuant to Rule 144 promulgated under the Securities Act
of  1933  (as  amended),  Section  16 of the Securities Exchange Act of 1934 (as
amended)  and the rules and regulations promulgated thereunder, or any successor
laws   and  regulations,  as  a  consequence  of  the  undersigned's  ownership,
acquisition  or  disposition  of  securities  of the Company, and to do all acts
necessary  in  order  to  file  such  forms  with  the  Securities  and Exchange
Commission,  any  securities  exchange  or national association, the Company and
such  other  person  or  agency  as  the  attorney  shall  deem appropriate. The
undersigned  hereby  ratifies  and  confirms all that said attorneys in fact and
agents shall do or cause to be done by virtue hereof.

      This Limited Power of Attorney shall remain in full force and effect until

the  undersigned  is  no  longer required to file Forms 144, Forms 3, 4 and 5 or
Forms  ID  with  respect  to  the  undersigned's holdings of and transactions in
securities  issued by the Company unless earlier revoked by the undersigned in a
writing delivered to the foregoing attorneys-in-fact.

      This Limited Power of Attorney is executed as of the date set forth below.

/s/ David R. McAvoy
----------------------------
Signature

David R. McAvoy
----------------------------
Print Name

Dated: November 9, 2018

Witness:

/s/ Fenella L. Harris
----------------------------
Signature

Fenella L. Harris
----------------------------
Print Name

Dated: November 9, 2018